论文信息 - Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer. - 字舞流文

Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer.

Y. Shimada | S. Matsumoto | K. Muro | Y. Matsumura | K. Shirao | M. Gotoh | Y. Yamada | S. Matsumoto | H. Ohkura | A. Kannami | Y. Takamatsu | K. Takahashi | S. Baba | T. Yamao | M. Okuwa | Y. Miyata | K. Chin | Y. Yamada | K. Ito